Metabolomics Study of Zebrafish Embryos Exposed to PFOS and 6:2 FTSA
Perfluorooctane sulfonate (PFOS), a typical perfluorinated compound, has been restricted from production and use due to its adverse effects on organisms and ecosystems. It has been replaced by various emerging alternatives, including 6:2 fluorotelomer sulfonic acid (6:2 FTSA). Recently, 6:2 FTSA has been widely detected in aquatic environments; however, studies on its toxicity to aquatic organisms remain limited. To compare the toxic effects of PFOS and 6:2 FTSA on aquatic organisms, zebrafish embryos were exposed to each compound for 72 h. Toxic effects were evaluated, and alterations in endogenous metabolites and metabolic pathways in zebrafish embryos were analyzed using metabolomics. The study demonstrated that both PFOS and 6:2 FTSA induced malformations in zebrafish embryos, with 61 and 33 endogenous differential metabolites identified respectively, predominantly involving lipids and amino acid derivatives. PFOS induces immunotoxicity primarily by disrupting lipid metabolism pathways, thereby interfering with normal embryonic development. In addition, 6:2 FTSA exhibited neurotoxicity by affecting metabolic pathways such as dopaminergic synapses. This study elucidates the differential metabolic responses induced by PFOS and 6:2 FTSA in zebrafish embryos, providing a theoretical basis for assessing the health risks of PFOS alternatives.